← Back to Search
Nanoparticles And The Blood Coagulation System. Part II: Safety Concerns.
A. Ilinskaya, M. Dobrovolskaia
Published 2013 · Materials Science, Medicine
Referenced 1 time by Citationsy Users
Download PDFAnalyze on Scholarcy
Nanoparticle interactions with the blood coagulation system can be beneficial or adverse depending on the intended use of a nanomaterial. Nanoparticles can be engineered to be procoagulant or to carry coagulation-initiating factors to treat certain disorders. Likewise, they can be designed to be anticoagulant or to carry anticoagulant drugs to intervene in other pathological conditions in which coagulation is a concern. An overview of the coagulation system was given and a discussion of a desirable interface between this system and engineered nanomaterials was assessed in part I, which was published in the May 2013 issue of Nanomedicine. Unwanted pro- and anti-coagulant properties of nanoparticles represent significant concerns in the field of nanomedicine, and often hamper the development and transition into the clinic of many promising engineered nanocarriers. This part will focus on the undesirable effects of engineered nanomaterials on the blood coagulation system. We will discuss the relationship between the physicochemical properties of nanoparticles (e.g., size, charge and hydrophobicity) that determine their negative effects on the blood coagulation system in order to understand how manipulation of these properties can help to overcome unwanted side effects.
This paper references
Procoagulant properties of bare and highly PEGylated vinyl-modified silica nanoparticles.
R. Tavano (2010)
Interactions of liposomes and platelets.
L. W. Reinish (1988)
Ultrafine Particles Exert Prothrombotic but Not Inflammatory Effects on the Hepatic Microcirculation in Healthy Mice In Vivo
A. Khandoga (2004)
Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure.
H. Nabeshi (2012)
Quantum dots hold promise for early cancer imaging and detection
Pericles Pericleous (2012)
Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge.
M. Dobrovolskaia (2012)
Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effects
J. Corbalan (2011)
Pulmonary thrombosis in the mouse following intravenous administration of quantum dot-labeled mesenchymal cells
Y. Ramot (2010)
Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells.
D. Napierska (2009)
Pulmonary Biocompatibility Assessment of Inhaled Single-wall and Multiwall Carbon Nanotubes in BALB/c Mice*
P. Ravichandran (2011)
Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants.
K. Pulskamp (2007)
Polystyrene nanoparticles affecting blood coagulation.
C. Oslakovic (2012)
Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro.
M. Dobrovolskaia (2012)
Bioeffects of CdTe quantum dots on human umbilical vein endothelial cells.
L. Wang (2010)
Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation.
P. Bihari (2010)
Interactions of human endothelial cells with gold nanoparticles of different morphologies.
D. Bartczak (2012)
The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP).
V. Silva (2005)
Acute Toxicity and Prothrombotic Effects of Quantum Dots: Impact of Surface Charge
J. Geys (2008)
Fibrinogen clot induced by gold-nanoparticle in vitro.
G. Chen (2011)
Research Highlights Highlights from the latest articles in nanomedicine
I. Rubinstein (2012)
Involvement of reactive oxygen species in the metabolic pathways triggered by diesel exhaust particles in human airway epithelial cells.
A. Baulig (2003)
Platelet adhesion and fibrinogen deposition in murine microvessels upon inhalation of nanosized carbon particles
A. Khandoga (2010)
A Second-Generation Blood Substitute (Perfluorodichlorooctane Emulsion) Generates Spurious Elevations in Platelet Counts from Automated Hematology Analyzers
O. Cuignet (2000)
Inflammatory effect of intratracheal instillation of ultrafine particles in the rabbit: role of C-fiber and mast cells.
A. Nemmar (1999)
Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis
J. Corbalan (2012)
Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels
S. Krasnici (2003)
Liposomes and Blood Cells: A Flow Cytometric Study
I. Constantinescu (2003)
Iron core/shell nanoparticles as magnetic drug carriers: possible interactions with the vascular compartment.
I. Herrmann (2011)
Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs.
T. Xia (2009)
Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs.
J. Lu (2007)
Propofol versus sevoflurane: Bleeding in endoscopic sinus surgery
A. Beule (2007)
Multistability in platelets and their response to gold nanoparticles.
Suryyani Deb (2011)
Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles
J. Koziara (2005)
Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers.
S. Salvi (1999)
Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation.
C. Lam (2004)
CARDIOVASCULAR EFFECTS ASSOCIATED WITH AIR POLLUTION: POTENTIAL MECHANISMS AND METHODS OF TESTING
M. Utell (2002)
Negative regulation of fibrin polymerization and clot formation by nanoparticles of silver.
S. Shrivastava (2011)
Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats.
Mo-Tao Zhu (2008)
Mechanisms underlying nano-sized air-pollution-mediated progression of atherosclerosis: carbon black causes cytotoxic injury/inflammation and inhibits cell growth in vascular endothelial cells.
H. Yamawaki (2006)
Surface derivatization state of polystyrene latex nanoparticles determines both their potency and their mechanism of causing human platelet aggregation in vitro.
Catherine McGuinnes (2011)
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
A. AlKilany (2010)
The antithrombotic and antimicrobial properties of PEG-protected silver nanoparticle coated surfaces.
V. M. Ragaseema (2012)
Particulate matter in the environment: pulmonary and cardiovascular effects
E. Alfaro-Moreno (2007)
Interaction of RGD liposomes with platelets.
T. Nishiya (1996)
Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
A. Ilinskaya (2013)
The role of nanoparticle size in hemocompatibility.
A. Mayer (2009)
A microanalytic study of particles transport across the alveoli: role of blood platelets.
J. P. Berry (1977)
Cationic PAMAM dendrimers disrupt key platelet functions.
Clinton F Jones (2012)
Retention of perfluorochemicals in rat liver and spleen.
K. C. Lowe (1992)
Nanoparticle‐induced platelet aggregation and vascular thrombosis
Anna Radomski (2005)
Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage.
Y. Pan (2009)
Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis.
S. Tenzer (2011)
Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity
Eun-Ah Jun (2011)
Air pollution and markers of inflammation and coagulation in patients with coronary heart disease.
R. Rueckerl (2006)
Mechanistic study on toxicity of positively charged liposomes containing stearylamine to blood.
T. Nishiya (1995)
Disseminated intravascular coagulation in infectious disease.
M. Levi (2010)
Understanding biophysicochemical interactions at the nano-bio interface.
A. Nel (2009)
Mechanisms of thrombus formation.
B. Furie (2008)
Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats.
D. Warheit (2004)
Present Status of Clinical Studies of Fluosol‐DA (20%) in Japan
T. Mitsuno (1985)
Determinants of the thrombogenic potential of multiwalled carbon nanotubes.
A. Burke (2011)
Diesel Exhaust Particles in Lung Acutely Enhance Experimental Peripheral Thrombosis
A. Nemmar (2003)
Health hazards due to the inhalation of amorphous silica
R. Merget (2001)
Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors.
R. Campbell (2002)
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
P. Aggarwal (2009)
Blood coagulation on biomaterials requires the combination of distinct activation processes.
C. Sperling (2009)
Particulate Matter Air Pollution and Cardiovascular Disease: An Update to the Scientific Statement From the American Heart Association
R. Brook (2010)
Cytotoxicity of silica nanoparticles through exocytosis of von Willebrand factor and necrotic cell death in primary human endothelial cells.
A. Bauer (2011)
Phagocytosis of liposomes by human platelets.
R. Male (1992)
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles
K. Greish (2012)
Potential in vitro effects of carbon nanotubes on human aortic endothelial cells.
Valerie G Walker (2009)
Exposure to particulate air pollution and risk of deep vein thrombosis.
A. Baccarelli (2008)
Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.
N. Malik (2000)
Acute exposure to diesel exhaust increases IL-8 and GRO-alpha production in healthy human airways.
S. Salvi (2000)
Assessment of thrombogenic potential of liposomes.
G. Zbinden (1989)
Experimental exposure to wood smoke: effects on airway inflammation and oxidative stress
L. Barregård (2007)
Size effects of latex nanomaterials on lung inflammation in mice.
K. Inoue (2009)
Interactions of conventional or photopolymerized liposomes with platelets in vitro.
R. Juliano (1983)
Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice.
A. Shvedova (2005)
Pulmonary exposure to diesel exhaust particles induces airway inflammation and cytokine expression in NC/Nga mice
K. Inoue (2005)
Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects.
A. Nemmar (2004)
Exposure to Concentrated Ambient Air Particles Alters Hematologic Indices in Humans
A. Ghio (2003)
Passage of Inhaled Particles Into the Blood Circulation in Humans
A. Nemmar (2002)
Characterization of antiplatelet properties of silver nanoparticles.
Siddhartha S Shrivastava (2009)
Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers.
A. Erdely (2009)
Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways.
X. Liu (2010)
Spurious propofol‐induced coagulopathy in a patient with hepatic rupture
H. Thomson (2008)
Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study
D. Liao (2005)
Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells.
N. Stasko (2007)
Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.
M. Dobrovolskaia (2009)
Nanoparticles of a different source induce different patterns of activation in key biochemical and cellular components of the host response
A. Guildford (2009)
Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo.
D. Simberg (2009)
Carbon nanotubes activate blood platelets by inducing extracellular Ca2+ influx sensitive to calcium entry inhibitors.
Jana Šemberová (2009)
Carbon nanotubes activate store-operated calcium entry in human blood platelets.
S. Lacerda (2011)
Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis.
G. Vercellotti (1982)
An in vitro study of vascular endothelial toxicity of CdTe quantum dots.
Ming Yan (2011)
Promoting effects of nanoparticles/materials on sensitive lung inflammatory diseases
K. Inoue (2011)
The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles.
N. Li (2008)
Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and transformed endothelial cells.
Sudhir Dabbas (2008)
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
M. Lundqvist (2008)
Aggravating Impact of Nanoparticles on Immune-Mediated Pulmonary Inflammation
K. Inoue (2011)
The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications.
H. Vallhov (2006)
Do inhaled carbon nanoparticles translocate directly into the circulation in humans?
N. Mills (2006)
Diesel exhaust activates redox-sensitive transcription factors and kinases in human airways.
J. Pourazar (2005)
This paper is referenced by
An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Efficacy in Pancreatic Cancer.
T. Ji (2016)
The characterization of self-assembled nanostructures in whole blood
M. Pitman (2020)
Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
A. Ilinskaya (2013)
Silica Nanoparticles Effects on Blood Coagulation Proteins and Platelets
V. Gryshchuk (2016)
Hemostatic nanotechnologies for external and internal hemorrhage management.
L. Wang (2020)
Effects of acute systemic administration of TiO2, ZnO, SiO2, and Ag nanoparticles on hemodynamics, hemostasis and leukocyte recruitment
Nadine Haberl (2015)
Nanoparticles' interactions with vasculature in diseases.
J. K. Tee (2019)
Nanoparticles in Nanomedicine Application: Lipid-Based Nanoparticles and Their Safety Concerns
R. B. S. Mydin (2019)
Nanoparticules d'or à couronne polymère modulable : synthèse, interactions avec les systèmes biologiques et propriétés de radiosensibilisation
Marine Le Goas (2019)
Flow cytometric analysis of the physical and protein-binding characteristics of solid drug nanoparticle suspensions.
N. Liptrott (2015)
Identification of regulatory needs for nanomedicines
S. Bremer-Hoffmann (2018)
Nanoparticle Uptake by Plants: Beneficial or Detrimental?
I. Pacheco (2018)
Exploration of interactions of ‘blood-nano interface’ of carbon-based nanomaterials for biomedical applications
Vishal Singh (2019)
Evaluation of Biodistribution, Toxicology, and Toxicologic Pathology of Nanomaterials Used to Deliver Nucleic Acids
H. D. Liggitt (2019)
Integrative meta-analysis of publically available microarray datasets of several epithelial cell lines identifies biological processes affected by silver nanoparticles exposure.
S. Ghojavand (2019)
Luminescence and X-ray Absorption Properties of Uniform Eu3+:(H3O)Lu3F10 Nanoprobes
Daniel González-Mancebo (2019)
Nanotoxicology of Nanomaterials : New Opportunities and Challenges
A. Radomska (2016)
Controlling structural and magnetic properties of IONPs by aqueous synthesis for improved hyperthermia
D. Bonvin (2017)
Iron oxide nanoparticles improved biocompatibility and removal of middle molecule uremic toxin of polysulfone hollow fiber membranes
N. Said (2019)
Magnetoelectric Nanoparticles: Paradigm Shift in Biomolecular Diagnostics
Chooda Khanal (2016)
Systemic Review of Biodegradable Nanomaterials in Nanomedicine
S. Su (2020)
Challenges in the development of nanoparticle-based imaging agents: Characterization and biology.
Rachael M Crist (2020)
Magnetic nanoparticles for drug targeting: from design to insights into systemic toxicity. Preclinical evaluation of hematological, vascular and neurobehavioral toxicology.
M. Agotegaray (2017)
Impact of poly(lactic-co-glycolic acid) nanoparticle surface charge on protein, cellular and haematological interactions.
Gopikrishna J. Pillai (2015)
Unintended effects of drug carriers: Big issues of small particles
H. Parhiz (2018)
Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis.
Caitong Yu (2015)
Nanoparticles and the Blood Coagulation System
A. Ilinskaya (2016)
The Effects of Liposome Treatment on Red Blood Cells during Hypothermic Storage
L. Cavalcante (2017)
Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer‐Associated Fibroblast Activation
T. Ji (2016)
Vascular biosafety of commercial hydroxyapatite particles: discrepancy between blood compatibility assays and endothelial cell behavior
Catarina Santos (2018)
Ag2S-Glutathione quantum dots for NIR image guided photothermal therapy
M. Hashemkhani (2020)
Oxaliplatin–Biomimetic Magnetic Nanoparticle Assemblies for Colon Cancer-Targeted Chemotherapy: An In Vitro Study
Ylenia Jabalera (2019)See more